NDA at EKisaakate 2026
NDA team joined the Nabagereka of Buganda Kingdom for the 2026 Kisaakate themed on mental health. NDA is engaging over 400 young people from different schools on substance and drug misuse and abuse
NDA approves Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead
National Drug Authority has just approved Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead, a USA based company. This is a game-changer for HIV prevention, especially for those at high risk. This is great step towards ending AIDS by 2030
